| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,406,305 |
412,026 |
$99.14M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
552,614 |
485,889 |
$46.05M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
531,363 |
159,366 |
$35.37M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,427,961 |
397,225 |
$34.73M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,403,917 |
411,667 |
$33.01M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
670,554 |
193,646 |
$20.37M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
161,940 |
145,677 |
$18.79M |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
122,330 |
122,243 |
$15.81M |
| 90837 |
Psychotherapy, 53 minutes with patient |
113,778 |
34,682 |
$14.94M |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
481,751 |
139,801 |
$13.55M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
179,456 |
44,836 |
$13.06M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
218,150 |
124,965 |
$12.74M |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
574,708 |
167,094 |
$12.14M |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
86,598 |
86,437 |
$9.14M |
| 76641 |
|
78,392 |
50,102 |
$8.47M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
81,384 |
81,260 |
$8.24M |
| 90834 |
Psychotherapy, 45 minutes with patient |
65,131 |
23,957 |
$5.72M |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
101,726 |
101,677 |
$5.15M |
| 76830 |
Ultrasound, transvaginal |
34,755 |
34,357 |
$3.99M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
119,606 |
25,565 |
$3.78M |
| 76536 |
|
33,737 |
33,490 |
$3.60M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
23,501 |
23,473 |
$3.47M |
| 93975 |
|
17,193 |
16,872 |
$3.36M |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
29,426 |
29,299 |
$2.57M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
14,783 |
14,728 |
$2.51M |
| 97533 |
|
43,001 |
8,464 |
$2.34M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
54,417 |
34,713 |
$2.26M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
28,913 |
28,782 |
$2.13M |
| 93880 |
|
13,173 |
13,148 |
$2.13M |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
16,813 |
16,798 |
$2.02M |
| 71046 |
Radiologic examination, chest; 2 views |
64,369 |
64,108 |
$1.99M |
| 90791 |
Psychiatric diagnostic evaluation |
13,332 |
12,773 |
$1.90M |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
212,362 |
62,093 |
$1.77M |
| 76825 |
|
6,074 |
6,005 |
$1.66M |
| 77065 |
Tomosynthesis, mammo |
12,202 |
11,566 |
$1.55M |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
7,642 |
7,613 |
$1.53M |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
7,763 |
7,757 |
$1.52M |
| 93970 |
|
8,645 |
8,581 |
$1.46M |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
7,015 |
6,487 |
$1.40M |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
22,713 |
17,094 |
$1.33M |
| 19083 |
|
2,353 |
2,347 |
$1.28M |
| 97161 |
|
20,837 |
20,754 |
$1.28M |
| 77066 |
Tomosynthesis, mammo |
7,838 |
7,788 |
$1.27M |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
36,975 |
33,601 |
$1.26M |
| 97162 |
|
20,114 |
20,014 |
$1.26M |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
47,843 |
15,884 |
$1.23M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
3,726 |
3,713 |
$1.16M |
| 72197 |
|
3,315 |
3,312 |
$1.12M |
| 95923 |
|
10,757 |
10,740 |
$1.11M |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
7,235 |
7,234 |
$1.04M |
| 90785 |
|
75,273 |
25,932 |
$1.04M |
| 97535 |
Self-care/home management training, each 15 minutes |
41,712 |
14,066 |
$1.01M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
31,519 |
30,659 |
$997K |
| 93925 |
|
4,513 |
4,507 |
$956K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
4,126 |
3,781 |
$923K |
| 76642 |
|
11,020 |
9,421 |
$910K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
5,042 |
5,040 |
$889K |
| 93886 |
|
4,467 |
4,457 |
$850K |
| 95886 |
|
6,951 |
6,464 |
$804K |
| 73562 |
|
19,870 |
14,082 |
$802K |
| 76770 |
|
10,079 |
10,052 |
$799K |
| 92526 |
|
23,783 |
5,247 |
$750K |
| 93979 |
|
6,626 |
6,624 |
$747K |
| 93890 |
|
3,866 |
3,853 |
$740K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,414 |
6,389 |
$719K |
| 74178 |
|
2,045 |
2,041 |
$717K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,361 |
6,333 |
$700K |
| 73630 |
|
20,369 |
16,059 |
$698K |
| 97032 |
|
62,721 |
19,032 |
$677K |
| 93976 |
|
8,256 |
7,756 |
$671K |
| 72100 |
|
16,733 |
16,711 |
$649K |
| 74183 |
|
1,857 |
1,857 |
$636K |
| 93922 |
|
8,076 |
8,002 |
$634K |
| 73221 |
|
3,133 |
2,965 |
$617K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,734 |
2,676 |
$610K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
4,644 |
4,634 |
$601K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,548 |
5,405 |
$593K |
| 36466 |
|
467 |
302 |
$581K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
384 |
384 |
$580K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
9,773 |
5,822 |
$580K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
5,450 |
2,963 |
$564K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,717 |
1,712 |
$563K |
| 72141 |
|
3,173 |
3,167 |
$553K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
6,000 |
4,125 |
$539K |
| 97124 |
|
22,640 |
6,194 |
$536K |
| 95921 |
|
7,024 |
7,023 |
$516K |
| 93892 |
|
3,124 |
3,120 |
$516K |
| L3001 |
Foot, insert, removable, molded to patient model, spenco, each |
4,594 |
2,297 |
$515K |
| 95912 |
|
3,056 |
2,866 |
$510K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,927 |
2,907 |
$503K |
| 97165 |
|
5,358 |
5,351 |
$498K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
33,690 |
21,999 |
$497K |
| 67210 |
|
1,179 |
1,057 |
$496K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
6,196 |
5,885 |
$495K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
141,892 |
137,132 |
$493K |
| 31231 |
|
2,822 |
2,735 |
$485K |
| 19081 |
|
898 |
894 |
$475K |
| 99443 |
|
4,319 |
3,971 |
$473K |
| 71250 |
|
3,715 |
3,708 |
$471K |
| 77080 |
|
15,856 |
15,843 |
$461K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,912 |
3,893 |
$456K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
6,003 |
5,410 |
$442K |
| 77062 |
|
7,050 |
7,043 |
$441K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
4,094 |
3,039 |
$435K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
749 |
391 |
$425K |
| 93923 |
|
3,706 |
3,637 |
$424K |
| 92523 |
|
2,807 |
2,782 |
$406K |
| 99401 |
|
23,285 |
20,772 |
$395K |
| 73030 |
|
11,008 |
9,435 |
$375K |
| 70486 |
|
2,793 |
2,791 |
$368K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
19,042 |
17,448 |
$357K |
| 92250 |
|
9,928 |
9,889 |
$353K |
| 99051 |
|
75,268 |
43,378 |
$347K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
4,133 |
4,120 |
$332K |
| 97035 |
|
33,152 |
9,285 |
$326K |
| 77061 |
|
6,993 |
6,967 |
$325K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
3,482 |
2,967 |
$312K |
| 99442 |
|
4,169 |
3,901 |
$308K |
| 97164 |
|
8,181 |
7,207 |
$303K |
| 95913 |
|
1,432 |
1,395 |
$290K |
| 93000 |
|
19,735 |
19,370 |
$268K |
| 73610 |
|
7,372 |
6,196 |
$266K |
| 97116 |
|
14,477 |
4,224 |
$266K |
| 73130 |
|
7,315 |
5,589 |
$264K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
12,251 |
12,030 |
$254K |
| 90832 |
Psychotherapy, 30 minutes with patient |
3,678 |
1,219 |
$253K |
| 76775 |
|
5,700 |
5,673 |
$253K |
| 99490 |
Ccm add 20min |
7,770 |
7,751 |
$248K |
| 72050 |
|
4,624 |
4,615 |
$245K |
| 11730 |
|
3,007 |
2,933 |
$240K |
| 73718 |
|
1,072 |
1,022 |
$237K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
7,516 |
7,482 |
$231K |
| 90836 |
|
3,005 |
2,836 |
$224K |
| 93971 |
|
2,007 |
1,966 |
$223K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,740 |
1,709 |
$221K |
| 95911 |
|
1,380 |
1,307 |
$216K |
| 83970 |
|
5,086 |
5,066 |
$216K |
| 29200 |
|
8,827 |
2,667 |
$212K |
| 72110 |
|
4,277 |
4,273 |
$211K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
18,678 |
17,387 |
$211K |
| 93978 |
|
1,425 |
1,421 |
$210K |
| 73110 |
|
5,194 |
4,391 |
$209K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,735 |
2,677 |
$208K |
| 17110 |
|
1,916 |
1,672 |
$200K |
| 98928 |
|
3,573 |
2,449 |
$198K |
| 94010 |
|
7,926 |
7,215 |
$194K |
| 76870 |
|
1,991 |
1,990 |
$192K |
| 58340 |
|
805 |
801 |
$191K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,631 |
1,624 |
$190K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
4,618 |
4,614 |
$180K |
| 77049 |
|
516 |
516 |
$176K |
| 92134 |
|
5,147 |
4,874 |
$174K |
| 92540 |
|
2,239 |
2,234 |
$172K |
| 71271 |
|
1,327 |
1,326 |
$168K |
| 92546 |
|
2,221 |
2,216 |
$159K |
| 36478 |
|
147 |
95 |
$158K |
| 93325 |
|
6,116 |
6,032 |
$152K |
| 92587 |
|
4,166 |
4,153 |
$149K |
| 72040 |
|
4,079 |
4,067 |
$147K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
1,405 |
594 |
$147K |
| 95924 |
|
1,271 |
1,270 |
$147K |
| 99215 |
Prolong outpt/office vis |
972 |
803 |
$144K |
| 92060 |
|
2,306 |
2,299 |
$141K |
| 93931 |
|
1,502 |
1,501 |
$141K |
| 95910 |
|
1,185 |
1,145 |
$141K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,818 |
1,320 |
$139K |
| 10061 |
|
875 |
764 |
$137K |
| L3219 |
Orthopedic footwear, mens shoe, oxford, each |
1,535 |
767 |
$135K |
| 20611 |
|
1,454 |
1,253 |
$135K |
| 29515 |
|
1,821 |
1,816 |
$134K |
| L3215 |
Orthopedic footwear, ladies shoe, oxford, each |
1,638 |
859 |
$129K |
| 72082 |
|
1,884 |
1,879 |
$128K |
| 72070 |
|
4,089 |
4,071 |
$124K |
| 75574 |
|
511 |
508 |
$124K |
| L3060 |
Foot, arch support, removable, premolded, longitudinal/ metatarsal, each |
2,297 |
1,219 |
$123K |
| 99050 |
|
23,125 |
14,855 |
$123K |
| 73502 |
|
2,638 |
2,628 |
$123K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
2,201 |
997 |
$122K |
| 10040 |
|
1,061 |
926 |
$122K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
413 |
413 |
$122K |
| 29520 |
|
5,025 |
1,434 |
$122K |
| 90838 |
|
1,088 |
958 |
$117K |
| 76801 |
|
1,034 |
1,025 |
$115K |
| 95117 |
|
9,503 |
4,314 |
$112K |
| 95816 |
|
381 |
381 |
$111K |
| 88312 |
|
2,280 |
2,275 |
$110K |
| 82308 |
|
4,031 |
4,008 |
$110K |
| 29125 |
|
1,585 |
1,579 |
$109K |
| 82670 |
|
3,421 |
3,397 |
$101K |
| 84146 |
|
5,008 |
4,973 |
$101K |
| 12001 |
|
1,010 |
1,005 |
$99K |
| 92235 |
|
891 |
890 |
$99K |
| 93888 |
|
1,004 |
1,003 |
$98K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
966 |
875 |
$97K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,452 |
1,088 |
$93K |
| 64615 |
|
635 |
631 |
$93K |
| 92552 |
|
5,178 |
5,145 |
$92K |
| 36475 |
|
108 |
92 |
$92K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
217 |
215 |
$89K |
| 29530 |
|
4,185 |
1,094 |
$88K |
| 77072 |
|
3,364 |
3,364 |
$88K |
| 72195 |
|
390 |
387 |
$87K |
| 88313 |
|
2,993 |
2,974 |
$87K |
| 72146 |
|
527 |
523 |
$86K |
| 73140 |
|
2,379 |
2,338 |
$85K |
| 84403 |
|
3,079 |
3,052 |
$85K |
| 84681 |
|
4,078 |
3,955 |
$83K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,388 |
788 |
$82K |
| 70544 |
|
694 |
686 |
$81K |
| 84439 |
|
9,190 |
9,149 |
$80K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,284 |
9,236 |
$80K |
| 20610 |
|
1,250 |
850 |
$80K |
| 73560 |
|
2,270 |
1,662 |
$78K |
| 73522 |
|
1,417 |
1,417 |
$75K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
9,382 |
9,315 |
$74K |
| 92002 |
|
939 |
939 |
$74K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
505 |
495 |
$74K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,394 |
3,381 |
$72K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,392 |
3,379 |
$72K |
| 83001 |
|
3,694 |
3,668 |
$71K |
| 74018 |
|
2,386 |
2,338 |
$71K |
| 73080 |
|
2,120 |
1,866 |
$70K |
| 76882 |
|
1,574 |
1,292 |
$70K |
| 29240 |
|
3,137 |
825 |
$70K |
| 77085 |
|
1,355 |
1,355 |
$69K |
| L3202 |
Orthopedic shoe, oxford with supinator or pronator, child |
1,941 |
972 |
$68K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,032 |
7,015 |
$68K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
9,060 |
8,487 |
$67K |
| 86376 |
|
4,768 |
4,735 |
$67K |
| 83002 |
|
3,508 |
3,482 |
$67K |
| 69210 |
|
1,211 |
1,207 |
$65K |
| L3010 |
Foot, insert, removable, molded to patient model, longitudinal arch support, each |
570 |
290 |
$65K |
| A5500 |
For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe |
514 |
513 |
$64K |
| 99385 |
|
541 |
540 |
$63K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
835 |
825 |
$63K |
| 10060 |
|
533 |
498 |
$63K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,227 |
1,224 |
$63K |
| 86800 |
|
4,761 |
4,728 |
$62K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
560 |
560 |
$61K |
| 84144 |
|
2,874 |
2,861 |
$60K |
| 92567 |
|
4,376 |
4,124 |
$60K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,596 |
2,899 |
$59K |
| 95938 |
|
394 |
390 |
$59K |
| 10005 |
|
449 |
448 |
$59K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,080 |
4,001 |
$59K |
| 93229 |
|
161 |
160 |
$58K |
| 87070 |
|
7,422 |
6,791 |
$58K |
| 92537 |
|
2,187 |
2,182 |
$58K |
| 11721 |
|
2,351 |
2,338 |
$56K |
| 82024 |
|
1,362 |
1,356 |
$56K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
4,913 |
4,887 |
$54K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
10,329 |
5,036 |
$53K |
| 76377 |
|
1,324 |
1,263 |
$52K |
| J1756 |
Injection, iron sucrose, 1 mg |
2,414 |
897 |
$52K |
| 92083 |
|
871 |
869 |
$51K |
| 88342 |
|
1,412 |
1,209 |
$51K |
| 82607 |
|
4,069 |
4,051 |
$51K |
| 92522 |
|
683 |
682 |
$50K |
| 83525 |
|
4,199 |
3,898 |
$50K |
| 31575 |
|
433 |
432 |
$49K |
| 92588 |
|
906 |
897 |
$48K |
| 74740 |
|
547 |
546 |
$47K |
| 92524 |
|
631 |
631 |
$46K |
| 94060 |
|
1,028 |
997 |
$46K |
| 11056 |
|
1,160 |
1,149 |
$45K |
| 99222 |
Initial hospital care, per day, moderate complexity |
381 |
378 |
$45K |
| 97113 |
|
660 |
204 |
$44K |
| 73218 |
|
168 |
164 |
$44K |
| 73590 |
|
1,362 |
1,151 |
$44K |
| 80053 |
Comprehensive metabolic panel |
4,408 |
4,403 |
$43K |
| 76000 |
|
1,007 |
908 |
$43K |
| 82626 |
|
1,810 |
1,801 |
$43K |
| 81002 |
|
21,720 |
18,362 |
$43K |
| L3332 |
Lift, elevation, inside shoe, tapered, up to one-half inch |
898 |
441 |
$42K |
| 94729 |
|
1,114 |
1,095 |
$42K |
| 82728 |
|
3,058 |
3,055 |
$42K |
| 92286 |
|
1,164 |
1,156 |
$41K |
| 84481 |
|
4,637 |
4,604 |
$41K |
| 99350 |
Prolong home eval add 15m |
239 |
131 |
$40K |
| A9581 |
Injection, gadoxetate disodium, 1 ml |
341 |
340 |
$39K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
118 |
118 |
$39K |
| 92025 |
|
1,269 |
1,248 |
$39K |
| 99497 |
|
797 |
796 |
$39K |
| 82746 |
|
3,067 |
3,064 |
$38K |
| 76881 |
|
931 |
585 |
$37K |
| 70491 |
|
194 |
194 |
$37K |
| 97166 |
|
389 |
389 |
$36K |
| 92133 |
|
1,087 |
1,086 |
$35K |
| 72220 |
|
1,130 |
1,103 |
$35K |
| 88112 |
|
1,975 |
1,956 |
$35K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,375 |
2,221 |
$35K |
| 99205 |
Prolong outpt/office vis |
158 |
158 |
$34K |
| 92610 |
|
521 |
518 |
$34K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
271 |
267 |
$34K |
| 84442 |
|
3,951 |
3,928 |
$34K |
| 19084 |
|
84 |
70 |
$34K |
| L3000 |
Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each |
156 |
85 |
$34K |
| A5512 |
For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each |
514 |
512 |
$33K |
| 76827 |
|
469 |
453 |
$33K |
| 95943 |
|
400 |
399 |
$33K |
| 11732 |
|
1,296 |
1,290 |
$32K |
| 82533 |
|
1,905 |
1,898 |
$32K |
| 94727 |
|
1,111 |
1,092 |
$31K |
| 93015 |
|
512 |
509 |
$31K |
| 70480 |
|
194 |
194 |
$31K |
| 92557 |
|
967 |
962 |
$31K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,751 |
3,424 |
$30K |
| 99439 |
|
657 |
656 |
$30K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,063 |
1,062 |
$29K |
| 71045 |
Radiologic examination, chest; single view |
2,399 |
2,037 |
$29K |
| 92551 |
|
4,557 |
4,556 |
$27K |
| 80061 |
Lipid panel |
4,406 |
4,396 |
$26K |
| 87184 |
|
4,204 |
3,953 |
$26K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
92 |
91 |
$26K |
| 93702 |
|
258 |
255 |
$26K |
| 11421 |
|
260 |
135 |
$25K |
| 99441 |
|
607 |
570 |
$25K |
| 84480 |
|
4,421 |
4,413 |
$25K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
198 |
78 |
$25K |
| 92081 |
|
802 |
800 |
$25K |
| 12011 |
|
198 |
198 |
$24K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
203 |
203 |
$24K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,682 |
6,877 |
$24K |
| 73564 |
|
532 |
353 |
$24K |
| 76820 |
|
520 |
370 |
$23K |
| 76818 |
|
207 |
62 |
$23K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
104 |
104 |
$23K |
| 73700 |
|
176 |
164 |
$22K |
| 68761 |
|
138 |
108 |
$22K |
| 87428 |
|
690 |
685 |
$22K |
| 83735 |
|
4,358 |
4,354 |
$22K |
| 11901 |
|
358 |
290 |
$22K |
| 90686 |
|
6,235 |
6,222 |
$21K |
| 76885 |
|
193 |
192 |
$21K |
| L4396 |
Static or dynamic ankle foot orthosis, including soft interface material, adjustable for fit, for positioning, may be used for minimal ambulation, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
161 |
106 |
$21K |
| 82977 |
|
4,215 |
4,202 |
$21K |
| 90849 |
|
620 |
197 |
$21K |
| 84100 |
|
4,347 |
4,343 |
$21K |
| 70543 |
|
62 |
61 |
$21K |
| 73090 |
|
700 |
680 |
$21K |
| 96367 |
|
309 |
157 |
$20K |
| 86769 |
|
599 |
373 |
$20K |
| 99386 |
|
148 |
148 |
$20K |
| 11755 |
|
206 |
206 |
$19K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
1,100 |
984 |
$19K |
| 76857 |
|
503 |
498 |
$19K |
| 10120 |
|
111 |
111 |
$19K |
| 92579 |
|
681 |
664 |
$18K |
| 81000 |
|
4,955 |
4,836 |
$18K |
| 97163 |
|
295 |
294 |
$18K |
| 29131 |
|
301 |
294 |
$18K |
| 99349 |
|
150 |
85 |
$18K |
| 99406 |
|
1,557 |
1,222 |
$18K |
| 72114 |
|
270 |
270 |
$17K |
| 83615 |
|
3,312 |
3,307 |
$17K |
| 72052 |
|
264 |
264 |
$16K |
| 82550 |
|
3,253 |
3,248 |
$16K |
| 84550 |
|
3,499 |
3,491 |
$16K |
| 73552 |
|
433 |
381 |
$16K |
| 92653 |
|
280 |
278 |
$16K |
| 92555 |
|
1,112 |
1,097 |
$16K |
| 71100 |
|
415 |
415 |
$15K |
| 82627 |
|
687 |
687 |
$15K |
| 92201 |
|
715 |
715 |
$15K |
| 83540 |
|
3,021 |
3,018 |
$15K |
| 92550 |
|
1,051 |
1,032 |
$15K |
| 99305 |
|
215 |
182 |
$15K |
| 93268 |
|
95 |
95 |
$15K |
| 94618 |
|
604 |
604 |
$15K |
| 11720 |
|
688 |
684 |
$15K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,927 |
1,580 |
$15K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
139 |
136 |
$14K |
| 90674 |
|
638 |
634 |
$14K |
| 90756 |
|
482 |
480 |
$14K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
78 |
78 |
$14K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
1,246 |
1,038 |
$14K |
| 93351 |
|
76 |
76 |
$14K |
| J3415 |
Injection, pyridoxine hcl, 100 mg |
1,286 |
502 |
$14K |
| 29540 |
|
1,388 |
766 |
$14K |
| 80305 |
|
1,958 |
1,826 |
$13K |
| 76514 |
|
1,311 |
1,294 |
$13K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
72 |
72 |
$13K |
| 72170 |
|
441 |
440 |
$13K |
| 99402 |
|
2,343 |
2,029 |
$12K |
| 95930 |
|
148 |
146 |
$12K |
| 11900 |
|
264 |
237 |
$12K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
4,276 |
3,101 |
$12K |
| 20553 |
|
195 |
183 |
$12K |
| 93224 |
|
152 |
148 |
$12K |
| 27096 |
|
66 |
40 |
$11K |
| 88120 |
|
64 |
62 |
$11K |
| 76821 |
|
130 |
100 |
$11K |
| 83550 |
|
2,166 |
2,164 |
$11K |
| 57150 |
|
224 |
219 |
$11K |
| M0244 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
14 |
14 |
$11K |
| 70220 |
|
274 |
274 |
$11K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
568 |
550 |
$10K |
| 73060 |
|
319 |
295 |
$10K |
| 97026 |
|
2,095 |
725 |
$10K |
| 87340 |
|
958 |
957 |
$10K |
| 93298 |
|
532 |
532 |
$10K |
| L2820 |
Addition to lower extremity orthosis, soft interface for molded plastic, below knee section |
148 |
93 |
$10K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
6,327 |
3,945 |
$10K |
| 76813 |
|
78 |
78 |
$10K |
| 86708 |
|
960 |
959 |
$10K |
| 86803 |
|
963 |
960 |
$10K |
| 00731 |
|
85 |
85 |
$10K |
| 99243 |
|
93 |
91 |
$9K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
87 |
86 |
$9K |
| 98927 |
|
156 |
147 |
$9K |
| 74181 |
|
51 |
51 |
$9K |
| G0268 |
Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing |
190 |
188 |
$9K |
| 92521 |
|
90 |
90 |
$9K |
| 90694 |
|
205 |
205 |
$9K |
| 74019 |
|
230 |
229 |
$9K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
202 |
121 |
$9K |
| L1971 |
Ankle foot orthosis, plastic or other material with ankle joint, with or without dorsiflexion assist, prefabricated, includes fitting and adjustment |
53 |
38 |
$9K |
| 95812 |
|
27 |
27 |
$8K |
| 92145 |
|
648 |
634 |
$8K |
| 98925 |
|
264 |
187 |
$8K |
| 93350 |
|
52 |
52 |
$8K |
| 87110 |
|
994 |
993 |
$8K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
1,446 |
1,442 |
$8K |
| 11102 |
|
78 |
78 |
$7K |
| 72084 |
|
74 |
74 |
$7K |
| 92020 |
|
301 |
300 |
$7K |
| 64483 |
|
30 |
30 |
$7K |
| 99307 |
|
329 |
306 |
$7K |
| 86706 |
|
960 |
959 |
$7K |
| 86704 |
|
958 |
957 |
$7K |
| 95044 |
|
30 |
30 |
$7K |
| 86328 |
|
249 |
125 |
$7K |
| 92548 |
|
537 |
537 |
$7K |
| 95700 |
|
26 |
26 |
$7K |
| 99457 |
|
874 |
873 |
$7K |
| 73620 |
|
243 |
174 |
$6K |
| 93272 |
|
199 |
197 |
$6K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
114 |
114 |
$6K |
| 72131 |
|
54 |
54 |
$6K |
| 84305 |
|
296 |
296 |
$6K |
| 81025 |
|
3,165 |
3,056 |
$6K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
590 |
543 |
$6K |
| 88174 |
|
303 |
302 |
$6K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
121 |
121 |
$6K |
| 96127 |
|
1,079 |
1,022 |
$5K |
| J9035 |
Injection, bevacizumab, 10 mg |
68 |
64 |
$5K |
| 86580 |
|
1,074 |
1,072 |
$5K |
| 76981 |
|
374 |
374 |
$5K |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
408 |
198 |
$5K |
| 51741 |
|
436 |
423 |
$5K |
| 0072A |
|
114 |
114 |
$5K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
1,219 |
1,009 |
$5K |
| L3485 |
Heel, pad, removable for spur |
144 |
72 |
$5K |
| 92508 |
Group treatment of speech, language, voice, communication, and/or auditory processing disorder |
209 |
136 |
$5K |
| 95819 |
|
13 |
12 |
$5K |
| 95708 |
|
72 |
27 |
$5K |
| 99201 |
|
94 |
94 |
$5K |
| 0071A |
|
105 |
105 |
$5K |
| J2785 |
Injection, regadenoson, 0.1 mg |
24 |
24 |
$5K |
| 11100 |
|
78 |
78 |
$5K |
| 92225 |
|
160 |
82 |
$4K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
3,511 |
2,735 |
$4K |
| 90688 |
|
252 |
252 |
$4K |
| 99407 |
|
309 |
292 |
$4K |
| 83003 |
|
254 |
254 |
$4K |
| 17000 |
|
192 |
190 |
$4K |
| 51798 |
|
456 |
450 |
$4K |
| 0012A |
|
99 |
99 |
$4K |
| L3100 |
Hallus-valgus night dynamic splint, prefabricated, off-the-shelf |
106 |
53 |
$4K |
| 84702 |
|
324 |
318 |
$4K |
| 86762 |
|
256 |
256 |
$4K |
| 93356 |
|
292 |
291 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
61,515 |
57,806 |
$4K |
| 97168 |
|
64 |
64 |
$4K |
| 71101 |
|
90 |
90 |
$4K |
| 81003 |
|
2,020 |
1,981 |
$4K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
370 |
341 |
$4K |
| 92226 |
|
134 |
68 |
$4K |
| 80414 |
|
70 |
70 |
$4K |
| 86765 |
|
244 |
244 |
$3K |
| 84270 |
|
539 |
531 |
$3K |
| 72158 |
|
12 |
12 |
$3K |
| 92202 |
|
316 |
315 |
$3K |
| 92586 |
|
648 |
626 |
$3K |
| 99233 |
Prolong inpt eval add15 m |
33 |
13 |
$3K |
| 74170 |
|
13 |
13 |
$3K |
| 0011A |
|
79 |
79 |
$3K |
| 62323 |
|
14 |
14 |
$3K |
| 77081 |
|
852 |
852 |
$3K |
| 97760 |
|
97 |
97 |
$3K |
| 78306 |
|
12 |
12 |
$3K |
| 0031A |
|
103 |
103 |
$3K |
| 97039 |
|
421 |
131 |
$3K |
| 64484 |
|
30 |
30 |
$3K |
| 98926 |
|
76 |
71 |
$3K |
| 31237 |
|
18 |
13 |
$3K |
| 87081 |
|
561 |
555 |
$3K |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
715 |
274 |
$3K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
420 |
332 |
$3K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
69 |
42 |
$3K |
| 95027 |
|
109 |
109 |
$3K |
| 72202 |
|
68 |
68 |
$3K |
| 99454 |
|
361 |
359 |
$3K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
24 |
24 |
$3K |
| 95723 |
|
12 |
12 |
$3K |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
14 |
14 |
$3K |
| 73660 |
|
94 |
91 |
$3K |
| J3411 |
Injection, thiamine hcl, 100 mg |
1,131 |
435 |
$3K |
| 87807 |
|
219 |
212 |
$2K |
| 93320 |
|
39 |
39 |
$2K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
12 |
12 |
$2K |
| 92570 |
|
88 |
86 |
$2K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
1,307 |
1,307 |
$2K |
| 94621 |
|
15 |
15 |
$2K |
| 86141 |
|
234 |
234 |
$2K |
| 90656 |
|
1,269 |
1,264 |
$2K |
| 87210 |
|
639 |
639 |
$2K |
| 82784 |
|
72 |
72 |
$2K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
96 |
96 |
$2K |
| 90658 |
|
640 |
632 |
$2K |
| 99188 |
|
161 |
161 |
$2K |
| 57454 |
|
12 |
12 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
41 |
41 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
48 |
47 |
$2K |
| 73200 |
|
14 |
14 |
$2K |
| 93882 |
|
19 |
19 |
$2K |
| 86735 |
|
244 |
244 |
$2K |
| 86787 |
|
244 |
244 |
$2K |
| 88341 |
|
36 |
36 |
$2K |
| 72275 |
|
28 |
25 |
$2K |
| 86592 |
|
584 |
584 |
$2K |
| 86003 |
|
15 |
15 |
$2K |
| 0399T |
|
44 |
43 |
$2K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
249 |
234 |
$2K |
| 93040 |
|
215 |
214 |
$2K |
| 76942 |
|
41 |
38 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
11,097 |
10,976 |
$2K |
| 93228 |
|
161 |
160 |
$2K |
| 29580 |
|
42 |
40 |
$2K |
| 99383 |
|
12 |
12 |
$2K |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
80 |
77 |
$2K |
| 90715 |
|
349 |
349 |
$2K |
| L3260 |
Surgical boot/shoe, each |
68 |
68 |
$2K |
| 97010 |
|
31,107 |
11,988 |
$2K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
37 |
35 |
$1K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
69 |
53 |
$1K |
| 99381 |
|
12 |
12 |
$1K |
| 82565 |
|
329 |
329 |
$1K |
| 87631 |
|
35 |
35 |
$1K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,555 |
621 |
$1K |
| 82950 |
|
231 |
203 |
$1K |
| 60300 |
|
12 |
12 |
$1K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,033 |
874 |
$1K |
| 70360 |
|
36 |
36 |
$1K |
| L3216 |
Orthopedic footwear, ladies shoe, depth inlay, each |
13 |
13 |
$1K |
| 99342 |
|
14 |
14 |
$1K |
| 72081 |
|
26 |
26 |
$1K |
| 86677 |
|
466 |
457 |
$1K |
| 0004A |
|
23 |
23 |
$1K |
| 92585 |
|
12 |
12 |
$978.12 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
154 |
144 |
$956.92 |
| 29550 |
|
78 |
69 |
$956.30 |
| 36406 |
|
70 |
68 |
$886.56 |
| 92652 |
|
12 |
12 |
$883.92 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
214 |
187 |
$864.84 |
| 99304 |
|
13 |
13 |
$854.75 |
| 92553 |
|
41 |
41 |
$814.20 |
| 95012 |
|
94 |
83 |
$789.94 |
| 87077 |
|
77 |
75 |
$737.20 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
363 |
316 |
$731.85 |
| 84153 |
|
40 |
40 |
$710.09 |
| 86160 |
|
72 |
72 |
$693.66 |
| 70547 |
|
17 |
17 |
$675.09 |
| G0008 |
Administration of influenza virus vaccine |
161 |
161 |
$661.14 |
| 0013A |
|
26 |
26 |
$650.00 |
| J0613 |
Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg |
374 |
146 |
$629.89 |
| 94375 |
|
90 |
90 |
$624.04 |
| E0116 |
Crutch, underarm, other than wood, adjustable or fixed, with pad, tip, handgrip, with or without shock absorber, each |
51 |
51 |
$584.50 |
| 92511 |
|
13 |
13 |
$582.42 |
| 0134A |
|
17 |
17 |
$581.25 |
| L3908 |
Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf |
13 |
13 |
$570.00 |
| 90655 |
|
42 |
42 |
$568.48 |
| 71110 |
|
12 |
12 |
$564.58 |
| 0064A |
|
12 |
12 |
$541.32 |
| 99422 |
|
30 |
25 |
$529.92 |
| 11420 |
|
26 |
26 |
$492.80 |
| 0003A |
|
16 |
16 |
$480.00 |
| 73600 |
|
14 |
12 |
$427.64 |
| 0124A |
|
12 |
12 |
$426.25 |
| 94762 |
|
245 |
235 |
$423.36 |
| 97014 |
|
8,531 |
2,971 |
$412.78 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
29 |
28 |
$404.57 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
25 |
25 |
$375.00 |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
94 |
89 |
$366.17 |
| 87625 |
|
13 |
13 |
$365.69 |
| 85651 |
|
182 |
181 |
$363.78 |
| 92015 |
Determination of refractive state |
13,142 |
13,107 |
$363.14 |
| 84703 |
|
168 |
168 |
$338.80 |
| 88323 |
|
14 |
14 |
$330.56 |
| 69209 |
|
19 |
19 |
$328.38 |
| 94726 |
|
39 |
39 |
$321.23 |
| 90710 |
|
135 |
135 |
$299.42 |
| 81005 |
|
167 |
163 |
$298.74 |
| 96381 |
|
13 |
13 |
$292.76 |
| 83690 |
|
49 |
49 |
$283.97 |
| 90461 |
|
3,904 |
3,866 |
$274.14 |
| 99459 |
|
13 |
13 |
$270.48 |
| 94664 |
|
157 |
157 |
$263.32 |
| 83655 |
|
171 |
166 |
$259.24 |
| 76376 |
|
236 |
235 |
$257.51 |
| 87486 |
|
12 |
12 |
$257.16 |
| 87581 |
|
12 |
12 |
$257.16 |
| 97810 |
|
154 |
89 |
$254.08 |
| 84154 |
|
12 |
12 |
$249.81 |
| 11305 |
|
14 |
14 |
$245.28 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
16 |
12 |
$243.84 |
| 0001A |
|
31 |
31 |
$240.00 |
| Q2035 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) |
14 |
14 |
$230.40 |
| 96130 |
|
138 |
130 |
$225.04 |
| 94200 |
|
220 |
200 |
$219.48 |
| 94760 |
|
11,661 |
9,956 |
$212.00 |
| 82310 |
|
44 |
44 |
$203.20 |
| 90707 |
|
397 |
396 |
$200.00 |
| 86403 |
|
52 |
50 |
$195.00 |
| 11719 |
|
13 |
13 |
$194.04 |
| 82150 |
|
37 |
37 |
$187.36 |
| 92285 |
|
191 |
187 |
$182.17 |
| 84295 |
|
37 |
37 |
$177.97 |
| 96101 |
|
120 |
118 |
$167.52 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
69 |
69 |
$167.33 |
| 86703 |
|
14 |
14 |
$163.10 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
35 |
35 |
$162.96 |
| 90901 |
|
688 |
208 |
$161.72 |
| 90716 |
|
856 |
855 |
$160.00 |
| 36000 |
|
951 |
773 |
$151.64 |
| 86140 |
|
36 |
36 |
$147.60 |
| 85018 |
|
87 |
87 |
$138.58 |
| 84132 |
|
37 |
37 |
$138.04 |
| 84520 |
|
41 |
41 |
$132.48 |
| 83861 |
|
346 |
341 |
$125.45 |
| 90744 |
|
1,050 |
1,049 |
$122.88 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
188 |
179 |
$107.87 |
| G0445 |
High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes |
40 |
40 |
$102.58 |
| 99173 |
|
13,264 |
13,217 |
$94.29 |
| 90672 |
|
198 |
198 |
$86.79 |
| 82962 |
|
1,523 |
1,086 |
$78.80 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
235 |
118 |
$73.42 |
| 97802 |
|
6,444 |
6,408 |
$70.10 |
| 36410 |
|
1,444 |
1,328 |
$64.38 |
| J2704 |
Injection, propofol, 10 mg |
99 |
92 |
$58.54 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
104 |
36 |
$52.69 |
| 82270 |
|
14 |
14 |
$47.60 |
| 90633 |
|
981 |
980 |
$44.16 |
| 96161 |
|
14 |
13 |
$40.88 |
| 29130 |
|
27 |
27 |
$35.99 |
| 97803 |
|
1,090 |
1,081 |
$34.35 |
| 95831 |
|
30 |
27 |
$33.20 |
| 92547 |
|
746 |
744 |
$32.81 |
| P3001 |
Screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician |
16 |
16 |
$32.39 |
| 96160 |
|
13 |
13 |
$31.50 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
43 |
24 |
$28.86 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
15 |
15 |
$28.53 |
| 84436 |
|
887 |
864 |
$28.50 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
13 |
$13.47 |
| G0506 |
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) |
97 |
90 |
$10.79 |
| J7610 |
Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg |
67 |
61 |
$9.56 |
| 99174 |
|
625 |
625 |
$7.27 |
| 99177 |
|
142 |
141 |
$5.81 |
| 82247 |
|
186 |
185 |
$5.02 |
| 94761 |
|
54 |
41 |
$5.00 |
| J0612 |
Injection, calcium gluconate, not otherwise specified, 10 mg |
59 |
29 |
$2.95 |
| H0033 |
Oral medication administration, direct observation |
56 |
53 |
$1.12 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
16,838 |
14,917 |
$0.92 |
| 99001 |
|
441 |
415 |
$0.58 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
19 |
19 |
$0.17 |
| H0001 |
Alcohol and/or drug assessment |
1,976 |
1,956 |
$0.16 |
| 99000 |
|
40,168 |
34,323 |
$0.12 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
174 |
159 |
$0.03 |
| H0049 |
Alcohol and/or drug screening |
232 |
227 |
$0.01 |
| 90651 |
|
73 |
72 |
$0.01 |
| 99072 |
|
22,448 |
16,012 |
$0.00 |
| 90713 |
|
1,798 |
1,795 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,184 |
1,073 |
$0.00 |
| 90670 |
|
2,338 |
2,333 |
$0.00 |
| 99080 |
|
844 |
839 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
5,134 |
4,383 |
$0.00 |
| 90700 |
|
2,320 |
2,318 |
$0.00 |
| 98960 |
|
4,243 |
4,228 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
573 |
554 |
$0.00 |
| 90648 |
|
723 |
723 |
$0.00 |
| A4550 |
Surgical trays |
726 |
664 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
573 |
554 |
$0.00 |
| 90734 |
|
422 |
422 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
1,036 |
999 |
$0.00 |
| 99354 |
|
60 |
53 |
$0.00 |
| G9820 |
Documentation of a chlamydia screening test with proper follow-up |
2,256 |
2,131 |
$0.00 |
| G8476 |
Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg |
40 |
39 |
$0.00 |
| A4595 |
Electrical stimulator supplies, 2 lead, per month, (e.g., tens, nmes) |
532 |
528 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
1,069 |
979 |
$0.00 |
| 92582 |
|
525 |
519 |
$0.00 |
| 90671 |
|
450 |
449 |
$0.00 |
| S9470 |
Nutritional counseling, dietitian visit |
629 |
607 |
$0.00 |
| G9316 |
Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family |
99 |
83 |
$0.00 |
| G9551 |
Final reports for imaging studies without an incidentally found lesion noted |
454 |
454 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
207 |
195 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
224 |
203 |
$0.00 |
| 92504 |
|
89 |
88 |
$0.00 |
| 97799 |
|
457 |
108 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
199 |
189 |
$0.00 |
| 97012 |
|
115 |
50 |
$0.00 |
| 4040F |
|
27 |
26 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
86 |
82 |
$0.00 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
131 |
120 |
$0.00 |
| 91300 |
|
43 |
43 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
197 |
188 |
$0.00 |
| 82042 |
|
14 |
13 |
$0.00 |
| 83721 |
|
229 |
225 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
200 |
184 |
$0.00 |
| 99408 |
|
204 |
203 |
$0.00 |
| 90687 |
|
16 |
16 |
$0.00 |
| 3078F |
|
12 |
12 |
$0.00 |
| 99306 |
Prolong nursin fac eval 15m |
12 |
12 |
$0.00 |
| A4617 |
Mouth piece |
21 |
13 |
$0.00 |
| 94070 |
|
26 |
26 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
12 |
12 |
$0.00 |
| 90685 |
|
29 |
29 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
14 |
14 |
$0.00 |
| 99473 |
|
30 |
25 |
$0.00 |
| 75580 |
|
14 |
14 |
$0.00 |
| 95957 |
|
12 |
12 |
$0.00 |
| G8938 |
Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible |
13 |
12 |
$0.00 |
| 0690T |
|
94 |
94 |
$0.00 |
| 78725 |
|
14 |
12 |
$0.00 |
| G9920 |
Screening performed and negative |
12 |
12 |
$0.00 |
| 90681 |
|
12 |
12 |
$0.00 |
| 91307 |
|
295 |
277 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
1,090 |
902 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
3,129 |
2,982 |
$0.00 |
| 99058 |
|
667 |
632 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
6,880 |
5,759 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
2,271 |
1,694 |
$0.00 |
| 91301 |
|
114 |
113 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,542 |
1,409 |
$0.00 |
| 88738 |
|
252 |
252 |
$0.00 |
| 90680 |
|
922 |
921 |
$0.00 |
| 36416 |
|
1,616 |
1,570 |
$0.00 |
| 90677 |
|
253 |
253 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
83 |
37 |
$0.00 |
| 80329 |
|
37 |
36 |
$0.00 |
| 80050 |
General health panel |
417 |
417 |
$0.00 |
| 0346T |
|
144 |
144 |
$0.00 |
| 90697 |
|
42 |
42 |
$0.00 |
| 90619 |
|
365 |
365 |
$0.00 |
| G9275 |
Documentation that patient is a current non-tobacco user |
762 |
731 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
94 |
85 |
$0.00 |
| G8883 |
Biopsy results reviewed, communicated, tracked and documented |
125 |
125 |
$0.00 |
| 90647 |
|
658 |
657 |
$0.00 |
| 90698 |
|
545 |
544 |
$0.00 |
| 99070 |
|
17 |
15 |
$0.00 |
| 99172 |
|
227 |
227 |
$0.00 |
| G8430 |
Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an acute health crisis where time is of the essence and delay of treatment would jeopardize the patient's health status) |
210 |
175 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
128 |
103 |
$0.00 |
| 83014 |
|
182 |
182 |
$0.00 |
| A4556 |
Electrodes, (e.g., apnea monitor), per pair |
379 |
357 |
$0.00 |
| 99474 |
|
47 |
38 |
$0.00 |
| 90660 |
|
13 |
13 |
$0.00 |
| 90620 |
|
26 |
24 |
$0.00 |
| 90381 |
|
13 |
13 |
$0.00 |
| 84432 |
|
63 |
63 |
$0.00 |
| 90723 |
|
49 |
49 |
$0.00 |
| 99458 |
|
12 |
12 |
$0.00 |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
17 |
17 |
$0.00 |
| S9451 |
Exercise classes, non-physician provider, per session |
27 |
27 |
$0.00 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
18 |
18 |
$0.00 |
| 1036F |
|
26 |
26 |
$0.00 |
| G9637 |
Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique) |
44 |
44 |
$0.00 |
| 97550 |
|
47 |
40 |
$0.00 |
| 97750 |
|
16 |
16 |
$0.00 |
| 87632 |
|
37 |
37 |
$0.00 |
| 91306 |
|
16 |
16 |
$0.00 |
| 91303 |
|
28 |
28 |
$0.00 |
| J3490 |
Unclassified drugs |
19 |
16 |
$0.00 |
| 3074F |
|
27 |
26 |
$0.00 |
| G8711 |
Prescribed antibiotic on or within 3 days after the episode date |
14 |
14 |
$0.00 |
| 90696 |
|
12 |
12 |
$0.00 |
| 3008F |
|
21 |
20 |
$0.00 |